• Live from TTLC 2026: Emerging Molecular Targets in Non-Small Cell Lung Cancer (NSCLC)

In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores the evolving landscape of emerging molecular targets in NSCLC with Dr. Kelsey Pan and Rajat Thawani, live from the Targeted Therapies of Lung Cancer (TTLC) 2026 conference. The discussion highlights rare oncogenic drivers with a focus on clinical evidence, resistance mechanisms and trial design. The episode also addresses biomarker testing, the role of next-generation sequencing and liquid biopsy, and what the next five years may hold for precision treatment strategies in NSCLC. Guests: Kelsey Pan, MD, MPH Assistant Professor of Medicine Department of Hematology & Oncology, Thoracic Medical Oncology Section Emory University Winship Cancer Institute Rajat Thawani, MD Assistant Professor of Medicine Division of Hematology and Oncology Knight Cancer Institute, OHSU

You can listen to • Live from TTLC 2026: Emerging Molecular Targets in Non-Small Cell Lung Cancer (NSCLC) online on Radio and Podcast. Open the player on this page to stream the available audio.

• Live from TTLC 2026: Emerging Molecular Targets in Non-Small Cell Lung Cancer (NSCLC) is an episode from Lung Cancer Considered by Lung Cancer Considered.

This episode is 00:42:09 long.

This episode was published on Feb 24, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Lung Cancer Considered when more episodes are available from the podcast feed.